Geneto is a health-tech startup based in Estonia, offering innovative genetic testing solutions for lifestyle-related disease prevention purposes. Its slogan, "We offer innovative genetic testing solutions for lifestyle-related disease prevention purposes," reflects the company's core mission.
Founded in 2017, Geneto combines genetic science with a diet and fitness app, providing assistance to individuals in losing weight, eating healthier, and avoiding lifestyle diseases such as type 2 diabetes. Its unique approach to utilizing genetic insights for improving health sets it apart in the Health Care industry.
The company is currently engaging in a fundraising campaign on the Funderbeam platform, with the aim of garnering support for its innovative products and services. With a focus on B2C solutions, Geneto demonstrates potential for disruption in the health-tech space.
As an investor, it is crucial to monitor the progress and potential of Geneto, given its utilization of cutting-edge scientific advancements to address prevalent health concerns. The company's dedication to personalized health solutions positions it as a compelling prospect for venture capital investment.
There is no investment information
No recent news or press coverage available for Geneto.